Spark YG™ 570 anti-β-Amyloid, 17-24
View Cart or Continue shopping.
Description
Alzheimer’s disease is characterized by the accumulation of aggregated Aβ peptides in senile plaques and vascular deposits. Aβ peptides are derived from amyloid precursor proteins (APP) through sequential proteolytic cleavage of APP by β-secretases and γ-secretases generating diverse Aβ species. Aβ can aggregate to form soluble oligomeric species and insoluble fibrillar or amorphous assemblies. Some forms of the aggregated peptides are toxic to neurons.
PRODUCT DETAILS
Clone: 4G8
Antibody Type: Monoclonal
Reactivity: Human, Mouse
Format: Spark YG 570
Host: Mouse
Isotype: IgG2b, κ
Applications: IHC-P - Quality tested
Regulatory Status: RUO
Note to Purchaser: This product is manufactured and supplied by BioLegend, Inc. under an agreement between BioLegend, Inc. and Cytek Biosciences, Inc. Information related to this product is provided by BioLegend, Inc.